These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34356093)

  • 1. The Interplay between Nevi and Melanoma Predisposition Unravels Nevi-Related and Nevi-Resistant Familial Melanoma.
    Pellegrini S; Elefanti L; Dall'Olmo L; Menin C
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
    Newton-Bishop JA; Chang YM; Iles MM; Taylor JC; Bakker B; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Elliott F; Kanetsky PA; Harland M; Barrett JH; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2043-54. PubMed ID: 20647408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of hereditary melanoma and nevi. 1998 update.
    Greene MH
    Cancer; 1999 Dec; 86(11 Suppl):2464-77. PubMed ID: 10630172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy.
    Bale SJ; Chakravarti A; Greene MH
    Am J Hum Genet; 1986 Feb; 38(2):188-96. PubMed ID: 3456198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.
    Bertram CG; Gaut RM; Barrett JH; Pinney E; Whitaker L; Turner F; Bataille V; Dos Santos Silva I; J Swerdlow A; Bishop DT; Newton Bishop JA
    J Invest Dermatol; 2002 Oct; 119(4):961-5. PubMed ID: 12406345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Evidence for BRAF as a melanoma/nevus susceptibility gene.
    Jackson S; Harland M; Turner F; Taylor C; Chambers PA; Randerson-Moor J; Swerdlow AJ; dos Santos Silva I; Beswick S; Bishop DT; Newton Bishop JA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):913-8. PubMed ID: 15824163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
    Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
    Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility.
    Randerson-Moor JA; Gaut R; Turner F; Whitaker L; Barrett JH; Silva Idos S; Swerdlow A; Bishop DT; Bishop JA
    J Invest Dermatol; 2004 Oct; 123(4):755-9. PubMed ID: 15373781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
    Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
    J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired melanocytic nevi in childhood and familial melanoma.
    Vredenborg A; Böhringer S; Boonk SE; Gruis NA; Out-Luijting C; Kukutsch NA; Bergman W
    JAMA Dermatol; 2014 Jan; 150(1):35-40. PubMed ID: 24196164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex melanoma families are enriched for polygenic risk.
    Law MH; Aoude LG; Duffy DL; Long GV; Johansson PA; Pritchard AL; Khosrotehrani K; Mann GJ; Montgomery GW; Iles MM; Cust AE; Palmer JM; ; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Saw RPM; Scolyer RA; Martin NG; Hayward NK; MacGregor S
    Hum Mol Genet; 2020 Oct; 29(17):2976-2985. PubMed ID: 32716505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of cutaneous melanoma and nevi.
    Greene MH
    Mayo Clin Proc; 1997 May; 72(5):467-74. PubMed ID: 9146691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the interplay of telomeres, nevi and the risk of melanoma.
    Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
    PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
    Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
    J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.
    Roos L; Sandling JK; Bell CG; Glass D; Mangino M; Spector TD; Deloukas P; Bataille V; Bell JT
    J Invest Dermatol; 2017 Apr; 137(4):910-920. PubMed ID: 27993549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
    Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
    J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
    Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.